Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Leborgne

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Bioconjugate Chemistry|May 22, 2003
Synthesis of linear polyethylenimine derivatives for DNA transfectionBlandine Brissault, Antoine Kichler, Christine Guis, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 10, 2017
Histidine-rich designer peptides of the LAH4 family promote cell delivery of a multitude of cargoGilles Moulay, Christian Leborgne, A James Mason, et al.
Human Gene Therapy Methods|March 31, 2015
Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in vitro reporter systemAmine Meliani, Christian Leborgne, Sabrina Triffault, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donorsPhilippe Veron, Christian Leborgne, Virginie Monteilhet, et al.
Pharmaceutical Research|April 16, 2010
Design and evaluation of histidine-rich amphipathic peptides for siRNA deliveryBérangère Langlet-Bertin, Christian Leborgne, Daniel Scherman, et al.
Biochemistry|September 13, 2007
Self-promoted cellular uptake of peptide/DNA transfection complexesLydia Prongidi-Fix, Masae Sugawara, Philippe Bertani, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-Oh Han, Giuseppe Ronzitti, Benjamin Arnson, et al.
Molecular Therapy. Methods & Clinical Development|May 11, 2019
Erratum: Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-Oh Han, Giuseppe Ronzitti, Benjamin Arnson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 27, 2007
Optimising histidine rich peptides for efficient DNA delivery in the presence of serumA James Mason, Christian Leborgne, Gilles Moulay, et al.
Human Gene Therapy|January 26, 2010
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectorsSylvie Boutin, Virginie Monteilhet, Philippe Veron, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Bioconjugate Chemistry|May 22, 2003
Synthesis of linear polyethylenimine derivatives for DNA transfectionBlandine Brissault, Antoine Kichler, Christine Guis, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 10, 2017
Histidine-rich designer peptides of the LAH4 family promote cell delivery of a multitude of cargoGilles Moulay, Christian Leborgne, A James Mason, et al.
Human Gene Therapy Methods|March 31, 2015
Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in vitro reporter systemAmine Meliani, Christian Leborgne, Sabrina Triffault, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donorsPhilippe Veron, Christian Leborgne, Virginie Monteilhet, et al.
Pharmaceutical Research|April 16, 2010
Design and evaluation of histidine-rich amphipathic peptides for siRNA deliveryBérangère Langlet-Bertin, Christian Leborgne, Daniel Scherman, et al.
Biochemistry|September 13, 2007
Self-promoted cellular uptake of peptide/DNA transfection complexesLydia Prongidi-Fix, Masae Sugawara, Philippe Bertani, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-Oh Han, Giuseppe Ronzitti, Benjamin Arnson, et al.
Molecular Therapy. Methods & Clinical Development|May 11, 2019
Erratum: Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-Oh Han, Giuseppe Ronzitti, Benjamin Arnson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 27, 2007
Optimising histidine rich peptides for efficient DNA delivery in the presence of serumA James Mason, Christian Leborgne, Gilles Moulay, et al.
Human Gene Therapy|January 26, 2010
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectorsSylvie Boutin, Virginie Monteilhet, Philippe Veron, et al.
Pageof 5